Community Healthcare Trust (CHCT) Financials

Community Healthcare Trust (NYSE:CHCT) showed improved operating performance in the second quarter of 2026, but leverage and shareholder-equity trends remain important risks. Revenue was $31.3 million, up from $29.7 million in the restated second quarter of 2025, while net income improved to $2.4 million from a $12.6 million loss. The year-ago comparison was heavily affected by a $8.7 million provision for credit losses and other elevated expenses.

Operating cash flow remained a key strength. CHCT generated $17.5 million from operations in Q2 2026, up from $13.8 million in Q2 2025 and $12.7 million in Q3 2025. However, the company paid $13.8 million in dividends during the quarter, leaving only a modest amount of operating cash after distributions and capital spending.

• Operating cash flow is consistently positive: Quarterly operating cash flow has generally remained between approximately $12.6 million and $17.5 million across the reported periods, providing support for property investment, debt service and dividends.
• Q2 2026 earnings recovered materially: Net income increased to $2.4 million, compared with losses of $12.6 million in Q2 2025 and $10.4 million in Q2 2024.
• Revenue has trended higher over the period: Quarterly revenue rose from $21.8 million in Q3 2022 to $31.3 million in Q2 2026, supported primarily by other non-interest income.
• Asset growth continues: Total assets increased to approximately $1.00 billion in Q2 2026 from $811.9 million in Q3 2022, while net premises and equipment grew to $940.0 million from $729.9 million.
• Investment activity has become less cash-intensive recently: CHCT purchased no investment securities in Q2 2026, compared with $28.5 million in Q4 2025 and $28.5 million in Q1 2026. This helped reduce the quarter’s investing cash outflow to $3.6 million, although the change may reflect timing rather than a permanent shift.
• Income remains concentrated in other non-interest income: This category contributed $31.0 million of Q2 revenue, or nearly all of the company’s total revenue. Investors should monitor the composition and recurring nature of this income because it is less transparent than recurring rental revenue.
• Debt has increased substantially: Long-term debt rose to $559.3 million in Q2 2026 from $310.8 million in Q3 2022 and $500.1 million in Q2 2025. Debt growth has helped finance the larger asset base but increases refinancing and interest-rate risk.
• Interest costs are absorbing a significant amount of cash: Cash interest paid was $7.1 million in Q2 2026, up from $6.3 million in Q2 2025 and $2.2 million in Q3 2022. Rising interest costs could limit funds available for acquisitions and distributions.
• Dividend coverage is relatively narrow: The company paid $13.8 million in dividends against $17.5 million of operating cash flow in Q2 2026, before capital expenditures and other investing needs. The dividend therefore depends on sustained cash generation and access to financing.
• Shareholders’ equity and retained earnings have deteriorated: Total equity declined to $414.2 million in Q2 2026 from $437.8 million in Q2 2025 and $478.5 million in Q3 2022. Retained earnings remained negative at $317.5 million, compared with a $145.2 million deficit in Q3 2022.

Overall, CHCT’s latest quarter reflects a meaningful recovery from the unusually weak results reported in 2024 and early 2025, with stronger earnings and operating cash flow. Nevertheless, the company’s low cash balance of $2.7 million, rising debt burden, growing interest expense and declining equity base leave limited room for operational setbacks. Investors should focus on whether earnings remain recurring and whether future growth can be funded without further materially increasing leverage.